-
A number of neurotrophic factors have great promise for the treatment of neurologic diseases. Prior work showed that a number of neurotrophic factors appeared to have promise for treating ALS, as well as peripheral neuropathy.
-
This is the first reported clinical trial of the effects of creatine in sporadic ALS patients. The trial was carried out in The Netherlands.
-
In one of the more bizarre stories of the year, the FDA has uncovered files of counterfeit Procrit (epoetin alfaJohnson & Johnson) in routine surveillance. To make matters worse, the fake vials have been contaminated with bacteria and many contain no active ingredient.
-
-
Rheumatoid arthritis should be recognized as a marker of increased risk for myocardial infarction.
-
The FDA recently approved a new class of antiretroviral drug for treatment of patients with resistant HIV infections.
-
Keeping the INR in the range of 1.5 to 2.0 is safe and effective.
-
Adding continuous positive airway pressure (CPAP) to medical therapy in patients who have obstructive sleep apnea and congestive heart failure both improves systolic function and lowers blood pressure.
-
A high intake of nondairy protein may accelerate renal function decline in women with mild renal insufficiency.
-
Detection of Alzheimers Disease and Dementia in the Preclinical Phase; Shoe Design and Plantar Pressures in Neuropathic Feet; Serum Thyroid Stimulating Hormone in Assessment of Severity of Tissue Hypothyroidism in Patients with Overt Primary Thyroid Failure.
